Original language | English (US) |
---|---|
Pages (from-to) | 1010-1012 |
Number of pages | 3 |
Journal | Annals of the rheumatic diseases |
Volume | 78 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2019 |
Funding
Funding This study was funded through a McGill University Health Centre Research Award. EV receives a salary support from a Fonds de Recherche Qu\u00E9bec Sant\u00E9 Clinical Research Scholar-Junior 1 Award. SCB is supported by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science and ICT (NRF-2017M3A9B4050335). SJ is supported by The Danish Rheumatism Association (A-3865). AEC is supported by an Arthritis Society Chair in Rheumatic Diseases. The Hopkins Lupus Cohort is supported by a National Institutes of Health grant (R01 AR069572) awarded to MP. The Birmingham SLICC cohort was funded by a Lupus UK grant awarded to CG. Competing interests None declared. Patient consent for publication Not required. Ethics approval McGill University Health Centre. Provenance and peer review Not commissioned; externally peer reviewed. Data sharing statement No additional data available.
Keywords
- antiphospholipid antibodies
- epidemiology
- systemic lupus erythematosus
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology
- General Biochemistry, Genetics and Molecular Biology